Poulikos I Poulikakos

12PUBLICATIONS
39CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 25, 2026
Binding kinetics enable tumor-selective MAPK and growth suppression by a Type 1 RAF Inhibitor.

|Oct 15, 2026
MEKing Room: On the Quest for New Sources of Therapeutic Index in RAS/MAPK-Driven Cancers.

|Sep 29, 2026
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition.

|Aug 20, 2026
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition.

|Oct 15, 2025
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors.

Beau Baars, Ana Orive-Ramos, Matthew J Emmett

|Jan 30, 2025
Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer.

James J Asciolla, Xuewei Wu, Christos Adamopoulos

Pageof 2

Frequent Collaborators

4 joint publications

Stuart A Aaronson

4 joint publications

Evripidis Gavathiotis

4 joint publications

Jian Jin

3 joint publications

Bijaya Gaire